GSK366)(1953157-39-5)
- Name: GSK366)
- Synonyms:GSK 366 (GSK-366;GSK366);1,2-Benzisoxazole-3-propanoic acid, 5-chloro-6-[(1R)-1-(6-methyl-3-pyridazinyl)ethoxy]-;GSK336;3-{5-chloro-6-[(1R)-1-(6-methylpyridazin-3-yl)ethoxy]-1,2-benzoxazol-3-yl}propanoic acid
- Molecular Formula:C17H16ClN3O4
- Molecular Weight:361.78
- CAS Registry Number:1953157-39-5
- EINECS:
- Melting Point:610.7±50.0 °C(Predicted)
- Water Solubility:
Other Product
- 195259-86-0/1-Naphthalenecarboxylic acid, 1,2,3,4-tetrahydro-6-methoxy-2-oxo-, ethyl ester
- 19526-15-9/3-Phenyl-N-propionyl-L-Ala-L-Val-L-Leu-L-Ala-OMe
- 19530-66-6/ethyl endo-8-oxobicyclo[3.2.1]octane-3-carboxylate
- 19530-67-7/ethyl exo-8-oxobicyclo[3.2.1]octane-3-carboxylate
- 1953098-33-3/potassiuM (5-(difluoroMethoxy)pyridin-3-yl)trifluoroborate
- 1953108-82-1/Benzenamine, 2-(2-quinazolinyl)-
- 1953114-40-3/4-Amino-5,6-dihydro-2,2,5-trimethyl-1,3,5-oxadiazepin-7(2H)-one hydrochloride
- 1953114-50-5/Sarcosine-d3 t-Butyl Ester Trifluoroacetic Acid Salt
- 1953127-57-5/2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinolin-5-ylboronic acid
- 1953132-75-6/1H-Pyrido[3,4-b]indole, 1-[2,6-difluoro-4-[[1-(3-fluoropropyl)-3-azetidinyl]oxy]phenyl]-2-(2-fluoro-2-methylpropyl)-2,3,4,9-tetrahydro-3-methyl-, (1R,3R)-
- 1953133-33-9/3-((tert-butyldiphenylsilyl)oxy)-2,2-difluoropropan-1-ol
- 1953133-35-1/(R)-3-((1-(1H-indol-3-yl)propan-2-yl)amino)-2,2-difluoropropan-1-ol
- 1953134-15-0/1H-Pyrido[3,4-b]indole, 1-[4-[2-[3-(fluoromethyl)-1-azetidinyl]ethoxy]phenyl]-2,3,4,9-tetrahydro-3-methyl-2-(methylsulfonyl)-, (1S,3R)-
- 1953134-16-1/1H-Pyrido[3,4-b]indole, 1-[4-[2-[3-(fluoromethyl)-1-azetidinyl]ethoxy]phenyl]-2,3,4,9-tetrahydro-3-methyl-2-(methylsulfonyl)-, (1R,3R)-
- 1953137-58-0/Cholan-24-oic acid, 6-ethyl-3-hydroxy-7-oxo-, ethyl ester, (3α,5β,6β)-
- 1953146-66-1/Pentanoic acid, 5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-
- 1953146-81-0/4,11,14,17,20,23-Hexaoxa-7-azapentacosanamide, N-[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]-6,6-bis[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-25-hydroxy-8-oxo-
- 195314-73-9/N-benzyl-1-(1-benzylpiperidin-4-yl)methanamine
- 1953152-17-4/8-(6-Fluoropyridin-2-yl)-4-methyldihydro-4l4,8l4-[1,3,2]oxazaborolo[2,3-b][1,3,2]oxazaborole-2,6(3H,5H)-dione
- 1953157-39-5/GSK366)
- 195316-62-2/Quinoline, 4-butyl-1,2,3,4-tetrahydro-
- 1953176-77-6/3-Amino-2-methyl-2-propanol-d6
- 1953178-11-4/1,3,2-Dioxaborolane, 2-[(1R,2R)-2-(3-methoxyphenyl)cyclopropyl]-4,4,5,5-tetramethyl-, rel-
- 1953178-14-7/1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-[(1R,2R)-2-[3-(trifluoromethyl)phenyl]cyclopropyl]-, rel-
- 1953178-16-9/1,3,2-Dioxaborolane, 2-[(1R,2R)-2-(3,5-difluorophenyl)cyclopropyl]-4,4,5,5-tetramethyl-, rel-
- 1953178-17-0/1,3,2-Dioxaborolane, 2-[(1R,2R)-2-(2,4-difluorophenyl)cyclopropyl]-4,4,5,5-tetramethyl-, rel-
- 1953178-20-5/2-(1-(4-fluorophenyl)cyclopropyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
- 1953183-84-0/1-(2-Bromoethoxy)-4-fluoro-2-methoxybenzene
- 1953184-73-0/Spiro[benzofuran-2(3H),4'-piperidine]-1'-carboxylic acid, 1,1-dimethylethyl ester
- 195318-65-1/D-myo-Inositol, 1-[(2R)-2,3-bis[(1-oxohexadecyl)oxy]propyl hydrogen phosphate] 3,4-bis(dihydrogen phosphate), pentasodium salt (9CI)